December 2017 |
End of year closureThe ENCePP Secretariat will remain closed from 22 December 2017 to 2 January 2018 inclusive. |
14 December 2017 |
Efficacy and safety studies on medicines (open tender ref. EMA/2017/09/PE)The European Medicines Agency has launched an open call for tender with the aim of establishing a number of framework contracts with research organisations for efficacy and safety studies on medicines to generate data and information to support regulatory decision-making, as and when required, for a period of four years. The specific studies may concern research under four different lots.
Related information: |
7 December 2017 |
2017 ENCePP plenary meetingThe meeting report and presentations from this year's ENCePP plenary meeting have been published and may be consulted in the documents section of the ENCePP website.
Related information: |
27 November 2017 |
EU PAS RegisterThe EU PAS Register will be affected by essential maintenance activities from Wednesday 29 November (18:00 UK time) through Friday 1 December. Service is expected to resume during Friday. During this period the EU PAS Register services will be limited. Certain study fields cannot be modified (Country, Substance, ATC Code and medical condition related information of a study). Users may continue to consult studies.
Related information: |
25 October 2017 |
ENCePP plenary meeting 2017The 16th ENCePP plenary meeting will be taking place at the premises of the European Medicines Agency in London on Tuesday, 21 November 2017. Participation is open to representatives from research centres and networks that have joined ENCePP.
Related information: |
9 October 2017 |
EU PAS RegisterThe EU PAS Register will be affected by essential maintenance activities scheduled to start at 18:00 (UK time) on Thursday 12 October which are expected to be concluded by 24:00 (UK time) on Friday 13 October. During this period the EU PAS Register services will be limited. Certain study fields cannot be modified (Country, Substance, ATC Code and medical condition related information of a study). Users may continue to consult studies.
Related information: |
29 September 2017 |
International Society of Pharmacovigilance (ISoP) Annual MeetingThe International Society of Pharmacovigilance (ISoP) annual meeting is taking place in Liverpool during October (16th-18th). In addition, there are two pre-conference workshops on 15th October. The conference programme will link traditional pharmacovigilance with innovate approaches from other sectors, including how novel analytical platforms provide both opportunities and challenges. For more information, including the programme, pre-conference workshops and registration, visit http://isop2017liverpool.org/ |
27 September 2017 |
ENCePP: 10 years of collaboration to strengthen the monitoring of benefits and risks of medicines in EuropeA new infosheet on ENCePP has been published to coincide with the 10 year anniversary of the network.
Related information: |
7 August 2017 |
EU PAS Register® The European Union Intellectual Property Office (EUIPO) has approved the registration of ‘EU PAS Register’ as a European Union trade mark.
Related information: » Platform for post-authorisation studies registered as EU trade mark |
6 July 2017 |
Sixth revision of the ENCePP Guide on Methodological Standards in PharmacoepidemiologyThe 6th revision of the ENCePP Methods Guide is now available on the ENCePP website. This latest version includes revisions, amendments and new references in all the chapters. Important changes were made to a number of chapters to take account of developments in some areas or the need for restructuring and clarification. Three new chapters have been added: Introduction, Patient registries, and Surveys.
Related information: » ENCePP Guide on Methodological Standards in Pharmacoepidemiology |
13 February 2017 |
ENCePP Work Plan 2017-2019The ENCePP Steering Group has adopted the network's new three year work plan. The main goal during 2017 to 2019 will be to optimise ENCePP's input to regulatory decision-making throughout the product life-cycle. Particular focus will be on the development of methods in impact research and to identify enablers and barriers to measuring the impact of pharmacovigilance.
Related information: |
10 February 2017 |
EU PAS RegisterThe European Union (EU) electronic Register of Post-Authorisation Studies (EU PAS Register) has reached a major milestone with 1000 registered studies in February 2017.
Related information: » Over 1,000 studies now recorded in EU register of post-authorisation studies |
20 January 2017 |
ENCePP activity report 2016The ENCePP Secretariat has published a summary of the network's activities in 2016. The report provides a list of key achievements, a number of metrics relating to the network's expertise and experience, plus some website statistics.
Related information: |